The gut microbiome as novel cardio-metabolic target: the time has come!
Key result
Intestinal microbiome emerges as a potential therapeutic target for cardiometabolic diseases.
Why the study?
The mechanisms by which intestinal microbiota and their metabolites influence systemic homeostasis and cardio-metabolic disease risks are not fully understood, and intervention studies are needed.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Intestinal microbes may modulate cardio-metabolic risk; leaves open whether targeted interventions improve outcomes.
PICO
P
Population
Cardio-metabolic diseases
I
Intervention / Comparator
Intestinal microbiome manipulation
The intestinal microbiome represents a new potential therapeutic target for the treatment of cardio-metabolic diseases.
Cite This Study
Vinje et al. (2013) conducted a review in Cardio-metabolic diseases. Intestinal microbiome manipulation was evaluated. The intestinal microbiome represents a new potential therapeutic target for the treatment of cardio-metabolic diseases, highlighting the need for future intervention studies.